Health Idea Now: CVS suspends sales of Zantac brand and generic heartburn drug during safety review

CVS Health Corp said on Saturday it will discontinue sales the popular Zantac heartburn treatment and its own generic ranitidine products from its pharmacies after traces of a known carcinogen were found in some of the products by the U.S. Food and Drug Administration.